Barriga, Danver Kayle .

HRN: 23-82-24  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/13/2025
CEFUROXIME 1.5GM (VIAL)
07/13/2025
07/20/2025
IV
350mg
Q8hours
PCAP-C
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: